Navigation Links
Proven Terumo Coronary Guidewire Technology Is Now Available in the United States
Date:9/12/2007

commented Dr. Lee Jobe of Wake Heart after testing the Runthrough NS.

"The launch of our first coronary product in the United States is very exciting," said Gary Clifton, Marketing Manager, Terumo Interventional Systems Coronary Product Line. "But more than that, to have a product received so well by the Cardiology community is a true testament to our heritage of product innovation."

For more information, customers can contact Terumo Interventional Systems by calling its Inside Sales Customer Care Team at 800-862-4143 or by visiting http://www.terumomedical.com/interventional.

Terumo Interventional Systems

Terumo Interventional Systems (TIS), a strategic business unit of Terumo Medical Corporation, directly markets a full line of guidewires, catheters, introducer sheaths, guiding sheaths and embolization products for use in a multitude of different interventional procedures.

Interventional Radiologists, Interventional Neuroradiologists, Interventional Cardiologists and Vascular Surgeons are among the medical professionals who depend upon TIS products to access and cross difficult-to- reach lesions thereby allowing therapeutic intervention in previously unreachable vascular beds.

Terumo Medical Corporation

Founded in 1972 as a Terumo Corporation subsidiary, Terumo Medical Corporation (TMC) develops, manufactures and markets high-quality medical devices used in a broad range of applications in numerous healthcare markets. TMC manufactures a broad portfolio of needles and syringes, entry-site management products, and a line of sterile connection devices used in hospitals and blood banks worldwide.

Terumo Corporation

Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with $2.3 billion in sales and operations in more than 150 nations. Founded in 1921, the company develops, manufactures and distributes world-c
'/>"/>

SOURCE Terumo Interventional Systems
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. TELITHROMYCIN - the proven effective new drug for cap
2. Partial-Breast Irradiation an Unproven Therapy
3. Drug-Coated Stents – Proven to be More Effectiv
4. “Provenge”, Dendritic cell vaccine for Prostate Cancr
5. Palatal Implant Procedure Proven Effective in Eliminating Snoring
6. New drug proven to tackle Type 2 Diabetes
7. No Proven Programs to Help Teens Quit Smoking
8. Young Adults Seldom Try Proven Methods to Kick the Butt
9. Clinically Proven Probiotic Supplement Now Available to Pharmacists
10. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
11. Coronary stent leads to complications
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Within3 Expands into Mobile Applications 2VoiceNation Calls on TASterix as Their CRM Solution 61493 1VoiceNation Calls on TASterix as Their CRM Solution 61493 2New York Personal Injury Law Firm Cellino 26amp 3B Barnes Wins 243 25 Million Settlement For Workers Injured in Truck Accident 61488 1New York Personal Injury Law Firm Cellino 26amp 3B Barnes Wins 243 25 Million Settlement For Workers Injured in Truck Accident 61488 2New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 1New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 2New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 3New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 4